Edward Spindler

Edward Spindler has extensive work experience in the pharmaceutical and biotechnology industry. Edward most recently served as the Vice President of Development at Aadi Bioscience, Inc, starting in November 2021. Prior to that, they held the role of Vice President at Immunomedics from March 2020 to February 2022. Mr. Spindler also worked at The Medicines Company, where they served as Vice President of Clinical & Non-Clinical Research from February 2014 to February 2022, and as Vice President of Research & Development Operations from February 2013 to February 2022. Edward was an Executive Consultant at Rosemont Research Inc from July 2018 to March 2020, and held the position of AVP - Pharmaceutical Development & Project Management at Genta, Inc from July 2003 to August 2012. Mr. Spindler began their career as a Consultant in Pharmaceutical Development at Rosemont Research, Inc from January 2001 to May 2003. Before entering the pharmaceutical industry, they worked as a Manager at AT&T from 1987 to 1997.

Edward Spindler has a diverse education history. Edward earned an MBA in Finance from The Wharton School in 1996-1997. Prior to that, they obtained a BS in Computer Science from Rutgers University in 1981-1983. In addition, they received an AAS in Applied Pulmonary Medical Science in 1975-1976 and another AAS in Allied Health Sciences in 1974-1976 from Brookdale Community College.